The US Food and Drug Administration (FDA) has approved a new chemotherapy drug called Ixempra (ixabepilone) for the treatment of advanced breast cancer. The announcement was made to the press by Bristol-Myers Squibb on 17th October, the maker of the new drug, who also said the drug will be available "within days". The drug was approved to treat patients with locally advanced breast cancer or with cancer that has started spreading to other parts of the body (metastatic), and is resistant or refractory to anthracyclines, taxanes, and capecitabine.
FDA Approves Chemotherapy Drug Ixempra For Advanced Breast Cancer
0 comments :
Post a Comment